Imiphumo ye-MXE ingaba yinto ehlukileyo kakhulu xa i-Dosage is Higher
Iimpembelelo zeMethoxetamine
I-Methoxetamine okanye i-MXE ineempembelelo ezikhuthazayo kunye ne-dissociative, kunye nemiphumo ekhuthazayo ephezulu kwizinga elisezantsi, kunye nemiphumo ye-dissociative kwimilinganiselo ephezulu. Abasebenzisi bezilwanyana eziphantsi kweyeza-20-milligrams-ingxelo baziva belile, benyuke ngamandla, bexhamla , kunye nokuxhatshazwa kwiingxaki kunye nexhala. Le mivakalelo ingakwazi ukuqhubeka njengento "emva kokuhamba" kweyure ukuya kwiiyure ezimbini emva kokuba iziphumo eziphambili zonyango zivale.
Kwimilinganiselo ephezulu (40-50mg), iziphumo ziyahluka kwaye zininzi kakhulu-kwaye zifana nezidakamizwa ezihlobene, i-ketamine kunye ne-PCP. Ezi zibandakanya iimvakalelo ezinxilisayo , i-auditory and mirucinations , kunye nomvakalelo wokuxhatshaliswa emzimbeni wakho. Kwakhona kubangele i-ataxia enamandla, eyenza ungenzi kunye kwaye unokubangela ubunzima bokuhamba okanye ukuhamba. I-Nystagmus iye yabikwa. Ngokuxhomekeke kwisetyenzisiweyo kunye nesimo sakho , kunye nokuphendula kwakho kwilisiza, unokufumana isimo esiluqukileyo sokuqonda esingahluka kwiimeko ezinjengophupha, ukuya kwimeko ekhohlakeleyo ehambelanayo yokukhathazeka okukhulu, enokuthi iqhubeke iiyure eziliqela. Isimo sokudibanisa , ngamanye amaxesha ekubhekiswe kubasebenzisi njengemitha engama-k-hole kwi-ketamine, kunokukwenza uzive ungaziqondi kunye nehlabathi elikujikelezile.
Izingozi zokuthatha i-MXE
Ulwazi oluncinci kakhulu lufumaneka malunga ne-MXE-ininzi i-anecodotal, ithunyelwe kwiiforam ze-intanethi ngabasebenzisi, okanye zixelwe ngamagqirha aphuthumayo asebenze ngamatyala achukumisayo.
Ezi ngxelo zinikezela ngcamango yento umntu athi ngayo malunga namava abo kunye neziyobisi, kodwa oku akunakwenzeka ukuba kuxelelwe amanye amava abasebenzisi. Ukungabikho kobungqina boluphando oluthembekileyo kwi-MXE kwenza kube yinto engengozini yokuthatha zombini ngexesha elifutshane kunye nexesha elide. Ngethuba elifutshane, ukuba unobungozi obukhulu besichengisisi, oogqirha abazama ukukunceda ekamelweni lokuxakeka ngokuqinisekileyo abanakukwazi kakuhle into oyenzile, okanye indlela yokuyiphatha kakuhle.
Ulwazi alukafumaneki kwimiphumo yexesha elide le-MXE, ngoko asikwazi ukuba ukuthatha i-MXE kungasichaphazela njani impilo yakho yengqondo okanye yempilo yakho, ukuzala kwakho, okanye impilo yengane yakho ukuba ukhulelwe okanye uncelisa xa Yithathe.
Iingxelo ze-Anecdotal ezivela kubasebenzisi zibonisa ukuba ukunyamezela kuyakha ngokukhawuleza, kwaye ukuba le nkunkuma inamandla okuba nomlutha . Abanye abasebenzisi babika ingxelo yokuthatha amanyathelo aphezulu ngamanqanaba emini ngomgudu wokugcina iziphumo ezintle kwizikolo zabo zokuqala eziphantsi. Oku kudla ngokubambisana neengxaki zengqondo, kunye neengxaki zentlalo ezichaphazelekayo.
Njengoko kunenkcazelo encinane kakhulu, abacebisi abaninzi abanomlutha kunye nabasebenzi bezonyango abanakuze bave ngeli chiza, mayeke wazi malunga neziphumo. Oku kunokwenza ulwalamano lwezobubele kunye nokunyangwa ngokukhawuleza kweziyobisi zalo mhlaza kunzima kakhulu.
I-MXE ekudibaniseni nezinye iziyobisi
I-Marijuana ibonakala iyomeleza i-MXE ngendlela engafanelekiyo, kubangela ukuphazamiseka okukhulu kunye nokuxinezeleka, intetho edibeneyo kunye nobunzima bokuthetha. Abasebenzisi banokuba ngamaqhina kunye ne- hyperpyrexic , engaba yingozi.
Imithombo
Anon. Ingxelo yomsebenzisi ekuthathe i-Methoxetamine (MXE). " Iforamu yaseSayin Exchange Exchange . Kuthunyelwe ngomhla we-10 kuSeptemba, 2012.
Hofer, K., Grager, B., Muller, D., Rauber-Luthy, C., Kupferscmidt, H., Rentsch, K., kunye noCeschi, A. "Imiphumo efana neCetamine emva kokusetyenziswa kwe-methoxetamine." U-Annal of Medicine Emergency 60: 97-99. 2012.
Ornella, C. et al. "I-Phenomenon yamachiza amatsha kwi-intanethi: Ityala le-ketamine elisuka kwi-methoxetamine." I-Psychopharmacology yabantu: iCliniki kunye noVavanyo , 27: 145-149. 2012.
Amatye, D., Davies, S., Puchnarewicz, M., Johnston, A. & Dargan, P. "Utywala obunobuninzi obunxulumene nokusetyenziswa kokuzonwabisa kwe-ketamine evela kwi-methoxetamine." I-European Journal ye-Clnical Pharmacology 68: 853-856. 2012.